JP2019060706A5 - - Google Patents

Download PDF

Info

Publication number
JP2019060706A5
JP2019060706A5 JP2017185200A JP2017185200A JP2019060706A5 JP 2019060706 A5 JP2019060706 A5 JP 2019060706A5 JP 2017185200 A JP2017185200 A JP 2017185200A JP 2017185200 A JP2017185200 A JP 2017185200A JP 2019060706 A5 JP2019060706 A5 JP 2019060706A5
Authority
JP
Japan
Prior art keywords
expression level
gene
prdm14
correlate
screening
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017185200A
Other languages
English (en)
Japanese (ja)
Other versions
JP6898617B2 (ja
JP2019060706A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2017185200A priority Critical patent/JP6898617B2/ja
Priority claimed from JP2017185200A external-priority patent/JP6898617B2/ja
Priority to PCT/JP2018/035395 priority patent/WO2019065609A1/ja
Priority to US16/650,415 priority patent/US20210208148A1/en
Priority to EP18861512.4A priority patent/EP3690444A4/en
Publication of JP2019060706A publication Critical patent/JP2019060706A/ja
Publication of JP2019060706A5 publication Critical patent/JP2019060706A5/ja
Application granted granted Critical
Publication of JP6898617B2 publication Critical patent/JP6898617B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017185200A 2017-09-26 2017-09-26 Ｐｒｄｍ１４発現を確認する方法 Active JP6898617B2 (ja)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2017185200A JP6898617B2 (ja) 2017-09-26 2017-09-26 Ｐｒｄｍ１４発現を確認する方法
PCT/JP2018/035395 WO2019065609A1 (ja) 2017-09-26 2018-09-25 Ｐｒｄｍ１４発現を確認する方法
US16/650,415 US20210208148A1 (en) 2017-09-26 2018-09-25 Method for confirming prdm14 expression
EP18861512.4A EP3690444A4 (en) 2017-09-26 2018-09-25 PROCEDURE FOR CONFIRMING EXPRESSION OF PRDM14

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2017185200A JP6898617B2 (ja) 2017-09-26 2017-09-26 Ｐｒｄｍ１４発現を確認する方法

Publications (3)

Publication Number Publication Date
JP2019060706A JP2019060706A (ja) 2019-04-18
JP2019060706A5 true JP2019060706A5 (enExample) 2020-11-05
JP6898617B2 JP6898617B2 (ja) 2021-07-07

Family

ID=65902885

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017185200A Active JP6898617B2 (ja) 2017-09-26 2017-09-26 Ｐｒｄｍ１４発現を確認する方法

Country Status (4)

Country Link
US (1) US20210208148A1 (enExample)
EP (1) EP3690444A4 (enExample)
JP (1) JP6898617B2 (enExample)
WO (1) WO2019065609A1 (enExample)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5219818B2 (enExample) 1973-03-30 1977-05-31
JP5219818B2 (ja) * 2006-09-27 2013-06-26 今井浩三 乳癌および卵巣癌の治療薬、検出方法ならびに検出用キット
WO2011085163A2 (en) * 2010-01-08 2011-07-14 The Regents Of The University Of California Protein markers for lung cancer detection and methods of using thereof
CA2815356A1 (en) * 2010-10-20 2012-04-26 Rush University Medical Center Lung cancer tests
JP6683986B2 (ja) * 2013-07-10 2020-04-22 国立大学法人 東京大学 がん幹細胞分子マーカー
US20150038365A1 (en) * 2013-08-01 2015-02-05 Meso Scale Technologies, Llc Lung cancer biomarkers
JP7136697B2 (ja) * 2015-09-25 2022-09-13 プロビスタ ダイアグノスティックス インコーポレイテッド デンスブレストを有する女性における乳癌の検出のためのバイオマーカー

Similar Documents

Publication Publication Date Title
JP7458678B2 (ja) タンパク質同定のためのデコーディングアプローチ方法
CN104704364B (zh) 用于先兆子痫和/或hellp综合征的预测或早期检测的生物标记物测试
EA201891580A1 (ru) Применение размера фрагмента бесклеточной днк для определения вариаций числа копий
EP4372383A3 (en) Methods and systems for protein identification
CA2798517A1 (en) Systems and methods of detecting and demonstrating hair damage via evaluation of protein fragments
WO2010021822A3 (en) Discovery of candidate biomarkers of in vivo apoptosis by global profiling of caspase cleavage sites
EP4254417A3 (en) Using nucleic acid size range for noninvasive prenatal testing and cancer detection
CN111684263A (zh) 血液分析系统、血液分析仪、血液分析方法及存储介质
Jiang et al. Gestational age assessment by methylation and size profiling of maternal plasma DNA: a feasibility study
CN106148524A (zh) 研究人体无精症和严重少精症快速检测的方法及应用其方法的试剂盒
JP2020533595A5 (enExample)
Uhlen Response to: Should we ignore western blots when selecting antibodies for other applications?
Rebolj et al. Incidence of cervical cancer after several negative smear results by age 50: prospective observational study
Park et al. Optimized combination of multiple biomarkers to improve diagnostic accuracy in male fertility
MX2025003617A (es) Metodos y productos para la identificacion de biomarcadores
JP2018525356A5 (enExample)
JP2019060706A5 (enExample)
WO2019089858A3 (en) Methods of assessing or monitoring a response to a cell therapy
Miller et al. Objective analysis of cancer stem cell marker expression using immunohistochemistry
WO2020123880A3 (en) Genomic rearrangements associated with prostate cancer and methods of using the same
GB2582074A (en) Methods and systems for detecting tissue conditions
JP2023156159A5 (enExample)
Machado et al. Isoenzyme electrophoresis and karyotype techniques as an alternative for cell line identity confirmation
JP2023551795A (ja) 非ヒトメタゲノム経路解析によるがん診断および分類
JP2022537448A (ja) 病態特異的抗原を同定するためのイムノームワイド関連研究